A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

NCT01241487 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypertension

Interventions

DRUG: valsartan/amlodipine

Sponsor

Novartis